Her2-positive/Low-expression Urinary and Digestive Tract Tumors Clinical Trials in Beijing, Beijing Municipality

A Study of BL-M07D1 in Patients With a Variety of Solid Tumors Including Locally Advanced or Metastatic HER2-positive/Low-expressing Urinary and Gastrointestinal Tumors